Johnny Mahlangu

0:03:42

Congress Overview and Medical Program Highlights with Professor Johnny Mahlangu

0:24:51

Black History Month - Starting the Conversation with Dr. Johnny Mahlangu

0:17:47

The evolving treatment landscape of hemophilia - Professor Johnny Mahlangu

0:30:55

7. New Standard of Care in Hemophilia: Dr. Johnny Mahlangu, South Africa

0:14:09

Haemophilia 2020 - What's New? Prof Johnny Mahlangu - 20201115

0:05:10

Bleeding Outcomes in Participants With Factor VIII Activity

0:52:15

Two year outcomes of gene therapy in Haemophilia A

0:29:48

Johnny Mahlangu: Global Perspective of Bleeding Disorders at SACC 2017

0:05:10

Efficacy and Safety of Valoctocogene Roxaparvovec 4 Years After Gene Transfer

0:01:22

WFH Gene Therapy Registry

0:05:08

Valoctocogene Roxaparvovec Gene Transfer for Severe Haemophilia A on Health-related Quality of Life

0:20:32

Extended Half-Life Products

0:27:32

Chapter 7: Treatment of Specific Hemorrhages

0:17:54

Episode 1 - WFH Congress Daily Recap

0:15:01

Healthy Living: What is Hemophilia?

0:08:04

Clinical trials phases

0:03:03

NNHF - Professor Johnny Mahlangu KNH Visit

0:07:01

Monitoring safety in clinical trials

0:27:22

Extended Half Life Clotting Factor Concentrates in Adolescents and Adults

0:22:09

CHS Rendez-vous 2023 / SESSION 1: INNOVATIVE COAGULATION THERAPIES – A REVOLUTION IN CARE

0:06:20

A four year update on valoctocogene roxaparvovec

0:57:52

WFH Webinar: Treatment Options for Hemophilia in the Developing World

0:04:21

Updates from the GENEr8-1 Trial

0:37:41

Acquired Haemophilia